Announcements Trials
Browse Landscape

Phase

Phase 2 59Phase 3 52Phase NA 27Phase 1 14Phase 1/2 8Phase 2/3 2Phase EARLY_PHASE1 1Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Glioma 6Glioblastoma 6Squamous Cell Carcinoma of Head and Neck 3Sarcoma 2Oligodendroglioma 2Neoplasm Metastasis 2Mycosis Fungoides 2Head and Neck Neoplasms 2Ependymoma 2Breast Neoplasms 2Astrocytoma 2Rectal Neoplasms 1Radiation Fibrosis Syndrome 1Prostatic Neoplasms 1Pelvic Neoplasms 1Ovarian Neoplasms 1Optic Nerve Glioma 1Neurotoxicity Syndromes 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Lung Neoplasms 1Invasive Breast Cancer 1Head and Neck Carcinoma of Unknown Primary 1Gliosarcoma 1Glioma, Subependymal 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Magnetic Resonance Spectroscopy 9gallium 68 PSMA-11 7Specimen Handling 42-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 4enzalutamide 2bicalutamide 2acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2Standard of Care 2Radiation 2Positron Emission Tomography Computed Tomography 2HhAntag691 2Abiraterone Acetate 268Ga-DKFZ-PSMA-11 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2xentuzumab 1trastuzumab biosimilar HLX02 1tislelizumab 1teprotumumab 1tazemetostat 1relugolix 1pertuzumab 1palbociclib 1olaparib 1niraparib 1gallium citrate 1eribulin 1entrectinib 1darolutamide 1cobimetinib 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Prostatic Neoplasms × Radiotherapy × Clear all
NCT03861676 2026-02-13

Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase EARLY_PHASE1 Recruiting
20 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡